Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neostigmine and Glycopyrrolate for Bowel Care in SCI
NCT04671030Phase 1Completed
- Sponsor
- James J. Peters Veterans Affairs Medical Center
- Start
- Jan 2018
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of neostigmine in neurogenic bowel (NBD) and constipation (2 arms), sponsored by James J. Peters Veterans Affairs Medical Center. Primary endpoint: Time to first bowel evacuation at 1 hour. Started Jan 2018; status: completed.
02
Drugs
neostigmine
03
Conditions
neurogenic bowel (NBD)constipation
Beyond the preview
Go deeper on NCT04671030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04671030.